1st Annual Symposium on Neonatal Resuscitation

1st Annual Symposium on Neonatal Resuscitation Banner

Date & Location
Thursday, November 16, 2017, 6:30 AM - 5:00 PM, OUHSC-Nicholson Tower, 940 NW 13th Street, Oklahoma City, OK

Target Audience
Anesthesiology, Cardiology, Neonatal-Perinatal Medicine , Obstetrics, Pediatrics, Respiratory Therapy


This conference will provide neonatal providers including physicians, nursed, nurse practitioners and respiratory therapists the opportunity to increase their knowledge base and discuss hot topics in the field of neonatal resuscitation with regional experts and opinion leaders. 

Nationally and internationally recognized experts will discuss clinical and scientific evidence of current DR practices through presentations and interactive sessions.  Regional leaders int he field will lead discussions on various clinical, scientific and ethical topics of neonatal interest.


Upon completion of this activity, participants will improve their competence and performance by being able to:
  1. Describe current Neonatal Resuscitation (NRP) recommendations for delivery room (DR) management of babies born with meconium-stained amniotic fluid (MSAF).
  2. Analyze science behind the the current Neonatal Resuscitation (NRP) recommendations for delivery room (DR) management of babies born with meconium-stained amniotic fluid (MSAF).
  3. Identify scenarios using simulation as teaching tools.
  4. Recognize the role of the Neonatologist in end of life (EOL) decisions in the delivery room.
  5. Discuss the different approaches for applying NRP guidelines in medically underserved areas.
  6. Explain how animal/manikin research can be applied to clinical DR settings.


Early Bird Rates (Register on or before September 29)
$250 Physicians
$75 Other Healthcare Providers (PA, NP, etc...) 

After September 29: 
$300 Physicians
$100 Other Healthcare Providers (PA, NP, etc...) 


The University of Oklahoma College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Oklahoma College of Medicine designates this live activity for a maximum of 6.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Conflict Resolution Statement

The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s speaker and planner disclosures and resolved all identified conflicts of interest, if applicable.

Nondiscrimination Statement

The University of Oklahoma, in compliance with all applicable federal and state laws and regulations does not discriminate on the basis of race, color, national origin, sex, sexual orientation, genetic information, gender identity, gender expression, age, religion, disability, political beliefs, or status as a veteran in any of its policies, practices, or procedures. This includes, but is not limited to: admissions, employment, financial aid, and educational services.

The University of Oklahoma is an equal opportunity institution. www.ou.edu/eoo

Accommodation Statement

Accommodations are available by contacting Chelsea Baker at (405) 271-5215  or chelsea-m-baker@ouhsc.edu as soon as possible.

Disclaimer Statement

Statements, opinions and results of studies contained in the program are those of the presenters and authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability.

Every reasonable effort has been made to faithfully reproduce the presentations and material as submitted. However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or operation of any methods, products, instruments or ideas contained in the material herein.

Policy on Faculty and Presenters Disclosure

It is the policy of the University of Oklahoma, College of Medicine that the faculty and presenters disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s).  

Description of how identified barriers will be addressed:

  1. Discrimination of current clinical DR practices and the supporting research evidence
  2. Explanation and discussion of the neonatologists ethical responsibilities in EOL care
  3. Recognition of clinically underserved areas and discussion of prudent resource allocation
  4. Appropriate teaching tools for health care delivery in these areas
  5. Identification of barriers (concrete or intangible) affecting streamlined and open communication pertinent to efficient resuscitation team function